Delivery Order SPE2DB22D2211-SPE2DB25FSCLE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,345.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as...
- The Defense Logistics Agency awarded a $1,107.78 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials under a firm fixed price contract effective August 18, 2025, with completion scheduled for August 19, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,357.30 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion date of September 17, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a direct fulfillment of pharmaceutical supply needs within the federal medical procurement system, specifically addressing vaccine...
- The Defense Logistics Agency awarded a $1,484.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on June 2, 2025, with an ultimate completion date of June 3, 2025. The contract, which is a child order under a larger vehicle, was performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and was awarded without a set-aside designation through open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $5,538.90 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 5, 2025. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and veteran healthcare systems through the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $113K to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected to...
- The Defense Logistics Agency awarded a delivery order valued at $11,473.57 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 7, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,925.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 11, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's standard federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,763.46 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract utilizing the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.76 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCLEDelivery Order
The Defense Logistics Agency awarded a $13,293.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 8, 2025. This non-set-aside contract was competitively awarded and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected to supply these immunization products to support military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and medical devices, to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. This delivery order represents a discrete fulfillment of vaccine requirements under that broader pharmaceutical prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 8/7/25 |